HomeCompareTHTX vs BTI

THTX vs BTI: Dividend Comparison 2026

THTX yields 59.00% · BTI yields 5.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 THTX wins by $582.4K in total portfolio value
10 years
THTX
THTX
● Live price
59.00%
Share price
$3.39
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$620.2K
Annual income
$143,088.77
Full THTX calculator →
BTI
BTI
● Live price
5.40%
Share price
$58.26
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.8K
Annual income
$2,802.29
Full BTI calculator →

Portfolio growth — THTX vs BTI

📍 THTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTHTXBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, THTX + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
THTX pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

THTX
Annual income on $10K today (after 15% tax)
$5,014.75/yr
After 10yr DRIP, annual income (after tax)
$121,625.45/yr
BTI
Annual income on $10K today (after 15% tax)
$459.05/yr
After 10yr DRIP, annual income (after tax)
$2,381.95/yr
At 15% tax rate, THTX beats the other by $119,243.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of THTX + BTI for your $10,000?

THTX: 50%BTI: 50%
100% BTI50/50100% THTX
Portfolio after 10yr
$329.0K
Annual income
$72,945.52/yr
Blended yield
22.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

THTX
Analyst Ratings
3
Buy
2
Hold
Consensus: Buy
Altman Z
-8.8
Piotroski
5/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.3% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

THTX buys
0
BTI buys
0
No recent congressional trades found for THTX or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTHTXBTI
Forward yield59.00%5.40%
Annual dividend / share$2.00$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3%
Portfolio after 10y$620.2K$37.8K
Annual income after 10y$143,088.77$2,802.29
Total dividends collected$512.6K$14.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: THTX vs BTI ($10,000, DRIP)

YearTHTX PortfolioTHTX Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$16,600$5,899.71$11,301$601.08+$5.3KTHTX
2$26,914$9,152.65$12,799$706.58+$14.1KTHTX
3$42,667$13,869.04$14,527$832.38+$28.1KTHTX
4$66,202$20,548.25$16,527$982.75+$49.7KTHTX
5$100,633$29,796.73$18,846$1,162.95+$81.8KTHTX
6$150,008$42,330.45$21,545$1,379.49+$128.5KTHTX
7$219,480$58,971.49$24,694$1,640.41+$194.8KTHTX
8$315,482$80,637.85$28,378$1,955.69+$287.1KTHTX
9$445,892$108,326.32$32,702$2,337.79+$413.2KTHTX
10$620,193$143,088.77$37,794$2,802.29+$582.4KTHTX

THTX vs BTI: Complete Analysis 2026

THTXStock

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH1902, which is in Phase 1/Part A clinical trials for the treatment of triple negative breast cancer; and TH1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Full THTX Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this THTX vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

THTX vs SCHDTHTX vs JEPITHTX vs OTHTX vs KOTHTX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.